
The first major rewrite since 2015 sorts therapies by mechanism of action, splits care into reactive and proactive phases, and adds guidance on 2 newer Janus kinase (JAK) inhibitors.
Check out this week’s highlights.
You did it—you made it to Friday! While you prepare for the weekend, catch up on hot topics and the latest trends in veterinary medicine.
Here is what you can find on dvm360® this week:
Have you registered for our Fetch dvm360® conference in Charlotte, North Carolina yet? Don’t worry there is still time so sign up






